Current Signal Transduction Therapy
Volume 16, 3 Issues, 2021
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Meet the Executive Guest Editor(s)
 |
Andrei M. Cardoso Federal University of Fronteira Sul Medicine Course Chapeco |
Dr. Cardoso is a Professor of Biochemistry and Immunology of the Medicine Course at Federal
University of Fronteira Sul (Brazil). For over 10 years, her research group has a long-standing
interest in the mechanisms related to the involvement of purinergic signaling and oxidative injury
in various diseases, especially on many types of cancer, sepsis, as well as others non communicable
diseases such as hypertension. The focus of her research has been the physiopathology
mechanisms and the role of ectonucleotidases and ATP on disease development. Dr. Cardoso has
authored more than 30 pubmed-indexed manuscripts.
|
Editor-in-Chief
Jingxuan Yang
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net